«Novel Approaches to Treat Obesity and Diabetes» Dr. Timo Müller, Institut for Diabetes and Obesity, Helmholtz Center Munich

Our group has together with lead international scientists pioneered the concept of polypharmacology by generating peptides which combine, through intermixed sequence hybridization, the beneficial effects of several key metabolic hormones into a single hormone entity.  The concept has previously been expanded by generation of peptides that shuttle nuclear hormones seletively in key metabolic orrgans. 

Dr. Timo Müller studied Animal Physiology in Marburg, Germany. Postdoc in the Metabolic Diseases Institute, University of Cincinnati, USA. Since 2011 Head of Division of Molecular Pharmacology, Helmholtz Center Munich. Since 2015 Associate Director of the Institute for Diabetes and Obesity, Helmholtz Center Munich.